PPT-HPV and Cervical Screening The Facts: A Health Promotion Initiative

Kelly S Mc Fadden SL School of Life and Health Sciences University of Ulster Jordanstown Introduction Aim Methodology The aetiological factors associated with cervical cancer are relatively unknown however scientific evidence links persistent infection with human papilomavirus HPV and the development of cervical carcinomas . . KrisEmily. . McCrory. , MD. Objectives:. Review cervical cancer epidemiology and . pathophysiology. Identify the role of the Human . Papilloma. Virus in cervical cancer. Explain the use of HPV testing in cervical cancer screening. Based on 2012 Guidelines & Recommendations. Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.. The American Society for Colposcopy and Cervical Pathology. “Cervical Cancer Screening Recommendations, . Based on the 2012 Recommendations (ASCCP). Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.. The American Society for Colposcopy and Cervical Pathology. “Cervical Cancer Screening Recommendations, . The Obstetrics & Gynecological Society of Bhopal. &. AMPOGS Research Public Welfare Society. BREAST . AND GENITAL TRACT CANCER INCIDENCE RATES PER 100,000 . FEMALES worldwide. 31.3. 17.4. 8.3. S.A. . Nadji. , PhD. Associate professor of virology. Head, Virology research center, . nritld. , . sbmu. . Ranking of the 7 most common HPV types . Type distribution for nearly 30’000 HPV related cancers from 38 countries participants in ICO surveys 2005 - 2014. Management of Abnormal Results. Kathy A. King, MD. Assistant Professor of OB/GYN. Medical Director, PPWI. Medical College of Wisconsin. May 6, 2016. Objectives. Overview of cervical cancer and oncogenic HPV. 141. st. APHA Annual Meeting. November 2013. Richard A. Crosby, PhD. University of Kentucky College of Public Health. Department of Health Behavior. . Presenter Disclosures. (1) The following personal financial relationships with commercial interests relevant to this presentation existed during the past 12 months:. Objectives . 1. What is cervical cancer?. 2. Who gets cervical cancer?. 3. Can it be prevented?. 4. What treatment is available?. . Quiz time!. Which viral infection is the most common cause of cervical cancer?. Prepared by : . Khalid . Aldossari. Fahad. . Alshehri. Ali Al-Mater. Supervised by : Dr. ELSHEIKH. Out lines :. WHO principles for screening tests .. HPV ( . infection , prevention , vaccination . CERVICAL CANCER. 4th most common cancer in women worldwide. CERVICAL CANCER. 4th most common cancer in women worldwide. >250,000 deaths/year. CERVICAL CANCER. 4th most common cancer in women worldwide. Selemawit. Ghebrendrias. 1. , Sarah Pfeil. 1. , Sheila K. Mody. 1. , Bonnie Crouthamel. 1. , Morgen Chalmiers. 1. , . Gennifer. Kully. 1. 1. Division Of Family Planning, Department Of Obstetrics, Gynecology, And Reproductive Sciences, University Of California, San Diego. Screening Programme. Dr G Dorman. QA Lead for Colposcopy. Cervical cancer. 80-90 new cases of invasive cervical cancer per year . 30-40 deaths per year. Associated with persistent infection with high risk subtypes of Human Papilloma Virus (HPV). Case Studies. Learning objectives. Demonstrate current knowledge of the National Cervical Screening Program (NCSP) and how this applies to clients. . Case study 1 - Jenny. Jenny 24 y.o. attends your clinic for a routine appointment, and you notice she is overdue for cervical screening. She received her full HPV vaccination in high school. . (Preliminary Results). Hawa Camara. |. November 17. th. , 2018. Facts about Cervical cancer in PNG. 2. Experiences of PoC HPV-DNA cervical screening in PNG. Need for improved screening services. 3.